このエントリーをはてなブックマークに追加
ID 65041
フルテキストURL
fulltext.pdf 1.68 MB
著者
Asano, Yosuke Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences ORCID
Matsumoto, Yoshinori Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences Kaken ID researchmap
Wada, Jun Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences ORCID Kaken ID publons researchmap
Rottapel, Robert Princess Margaret Cancer Center, University Health Network, University of Toronto
抄録
Ubiquitin-mediated proteasomal degradation is a post-transcriptional protein modification that is comprised of various components including the 76-amino acid protein ubiquitin (Ub), Ub-activating enzyme (E1), Ub-conjugating enzyme (E2), ubiquitin ligase (E3), deubiquitinating enzyme (DUB) and proteasome. We and others have recently provided genetic evidence showing that E3-ubiquitin ligases are associated with bone metabolism, the immune system and inflammation through ubiquitylation and subsequent degradation of their substrates. Dysregulation of the E3-ubiquitin ligase RNF146-mediated degradation of the adaptor protein 3BP2 (SH3 domain-binding protein 2) causes cherubism, an autosomal dominant disorder associated with severe inflammatory craniofacial dysmorphia syndrome in children. In this review, on the basis of our discoveries in cherubism, we summarize new insights into the roles of E3-ubiquitin ligases in the development of human disorders caused by an abnormal osteoimmune system by highlighting recent genetic evidence obtained in both human and animal model studies.
キーワード
E3-ubiquitin ligases
ubiquitylation
proteasomal degradation
osteoimmunology
cherubism
発行日
2023-02-23
出版物タイトル
Frontiers in Immunology
14巻
出版者
Frontiers Media
開始ページ
1120710
ISSN
1664-3224
資料タイプ
学術雑誌論文
言語
英語
OAI-PMH Set
岡山大学
著作権者
© 2023 Asano, Matsumoto, Wada and Rottapel.
論文のバージョン
publisher
PubMed ID
DOI
Web of Science KeyUT
関連URL
isVersionOf https://doi.org/10.3389/fimmu.2023.1120710
ライセンス
https://creativecommons.org/licenses/by/4.0/
Citation
Asano Y, Matsumoto Y, Wada J and Rottapel R (2023) E3-ubiquitin ligases and recent progress in osteoimmunology. Front. Immunol. 14:1120710. doi: 10.3389/fimmu.2023.1120710